Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun;9(6):e438-e448.
doi: 10.1016/S2352-3018(22)00125-4. Epub 2022 May 13.

Unified European support framework to sustain the HIV cascade of care for people living with HIV including in displaced populations of war-struck Ukraine

Affiliations
Free article
Review

Unified European support framework to sustain the HIV cascade of care for people living with HIV including in displaced populations of war-struck Ukraine

Marta Vasylyev et al. Lancet HIV. 2022 Jun.
Free article

Erratum in

  • Correction to Lancet HIV 2022; 9: e438-48.
    [No authors listed] [No authors listed] Lancet HIV. 2022 Dec;9(12):e822. doi: 10.1016/S2352-3018(22)00162-X. Epub 2022 May 31. Lancet HIV. 2022. PMID: 35659003 No abstract available.

Abstract

Ukraine is one of the countries in Europe most affected by HIV. The escalation of open war on the European continent has affected HIV care in Ukraine in an unprecedented way. Treating physicians in Europe have little experience on how to handle HIV-specific care under these circumstances. A framework is urgently needed that both defines and sets out strategies to handle the specific challenges for emergency support for people living with HIV, both those staying in Ukraine and those becoming displaced. The optimal allocation of the few available medical resources, primarily antiretroviral therapy, is necessary to best prevent individual morbidity and achieve population transmission control. Professional HIV networks play a central role to create, optimise, and execute support strategies. Through a rapid literature review we identified the key strategies needed to create a support framework, adapted to Ukraine's HIV epidemiology. We produce a unified support framework aiming to reduce the inevitable impact on Ukraine's HIV care cascade now, and when rebuilding it after the war.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests JIB declares grants or contracts from Gilead, Janssen, MSD, and ViiV healthcare; and consulting frees from Gilead, Janssen, MSD, and ViiV healthcare. OS declares grants and honoraria from Gilead. AL declares grants or contracts from Gilead, My Cartis, and ViiV healthcare; consulting fees from Janssen and ViiV healthcare; and payment of honoraria from Gilead, Janssen-Cilag, and ViiV healthcare. AC declares grants or contracts from Gilead; and payment or honoraria from Gilead, Janssen-Cilag, MSD, and ViiV healthcare. CDS declares payment or honoraria from AbbVie, AstraZeneca, Cepheid, Formycon, Gilead, GSK, Janssen, Molecular Partners, MSD, Roche, Swedish Orphan Biovitrium, and ViiV Healthcare; and support for attending meetings or travel, or both, from AbbVie, AstraZeneca, Cepheid, Formycon, Gilead, GSK, Janssen, Molecular partners, MSD, Roche, Swedish Orphan Biovitrium, and ViiV Healthcare. SN declares grants or contracts from Gilead and ViiV healthcare; consulting fees from Gilead, Janssen, MSD, and ViiV healthcare; payment or honoraria from Gilead, Janssen, MSD, and ViiV healthcare; and support for attending meetings or travel, or both, from Janssen, Gilead, and ViiV healthcare. AW declares grants and consulting fees from Gilead, Janssen, and ViiV healthcare. TJB declares grants or contracts from Gilead, Janssen, MSD, Roche, Thera, and ViiV healthcare; support for attending meetings or travel, or both, from Gilead, Janssen, MSD, Roche, Thera, and ViiV healthcare; consulting fees from Gilead, MSD, Roche, Thera, and ViiV healthcare; and payment or honoraria from Gilead, Janssen, MSD, Roche, Thera, and ViiV healthcare. LW declares consulting fees from Cipla, Gilead, Merck, Mylan, Theratech, ViiV healthcare; payment or honoraria from Gilead, Janssen, Merck, Mylan, Theratech, and ViiV healthcare; and research grants from Gilead, Janssen, and ViiV healthcare. SB declares consulting fees and honoraria from Gilead, MSD, Roche, Sobi, ViiV healthcare. CR declares support for the present manuscript from Aidsfonds and Dutch Federation Medical Specialists; grants or contracts from Erasmus MC Fellowship, Gilead, Health~Holland, Janssen, MSD, ViiV healthcare, and ZonMW; consulting fees from Gilead and ViiV healthcare; and payment or honoraria from Gilead, ViiV healthcare, and Virology Education. All other authors declare no competing interests.

Publication types